Aeovian Pharmaceuticals, Inc.

United States of America


 
Total IP 19
Total IP Rank # 79,565
IP Activity Score 2.2/5.0    21
IP Activity Rank # 39,231
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

8 1
3 1
5 1
0
 
Last Patent 2024 - Tricyclic fused imidazole compou...
First Patent 2020 - Mtorc modulators and uses thereof
Last Trademark 2020 - AEOVIAN
First Trademark 2019 - AEOVIAN

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Tricyclic fused imidazole compounds as cd38 modulators and uses thereof. The disclosure provides ...
2023 Invention Cd38 modulators and uses thereof. The disclosure provides compounds of Formula (I) and salts ther...
Invention Mtorc1 modulators and uses thereof. The disclosure provides compounds and salts that show high s...
2022 Invention Mtorc1 modulators and uses thereof. The disclosure provides compounds and salts that show high se...
2021 Invention Mtorc modulators and uses thereof. Novel rapamycin analogs and uses thereof are disclosed herein...
Invention Mtorc1 modulators and uses thereof. The disclosure provides rapamycin derivatives and salts that ...
Invention Mtorc modulators and uses thereof. Novel rapamycin analogs and uses thereof are disclosed herein....
2020 G/S Pharmaceuticals for the treatment of central nervous system (CNS), cardiovascular, metabolic, de...
G/S Pharmaceuticals; pharmaceuticals and therapeutics for treatment of age-related and genetic patho...
Invention Mtorc modulators and uses thereof. Novel rapamycin analogs and uses thereof are disclosed h...
2019 G/S Research and development of pharmaceuticals